Inflation Causes Fear Of Vietnam Drug Shortage
This article was originally published in PharmAsia News
Vietnam faces a possible shortage of drugs because of recent inflation-driven price increases, according to pharmaceuticals and hospitals represented at a conference. In Da Nang, the retail price of drugs has increased by as much as 30 percent during the past few months even though distributors are honoring contracts signed when prices were lower. Citing the increase, one hospital head said there was a chance hospitals in Vietnam soon would see a shortage of drugs. The head of the Ministry of Health's drug administration said the government would raise caps on drug prices the rest of this year, but only in sync with the consumer price index. (Click here for more
You may also be interested in...
Potentially transformative treatments for severe asthma, COPD and osteoarthritis are among some of the below-the-radar projects the Swiss major is advancing, according to Vas Narasimhan.
Pharma’s latest partnerships focus on Duchenne muscular dystrophy with Precision Biosciences, protein degradation with Seed. Bristol and Schrodinger team in computational drug discovery.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.